Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Grant/Award of 26,700 AVIR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 26,700 | n/a |
| Jan 26, 2026 | Coya Therapeutics, Inc. (COYA) | Grant/Award | 15,257 | n/a |
| Jun 24, 2025 | Atea Pharmaceuticals, Inc. (AVIR) | Grant/Award | 164,800 | n/a |
| Jan 13, 2025 | Coya Therapeutics, Inc. (COYA) | Grant/Award | 150,602 | n/a |
| Jun 6, 2024 | Coya Therapeutics, Inc. (COYA) | Grant/Award | 163,663 | n/a |
| Feb 3, 2024 | Coya Therapeutics, Inc. (COYA) | Grant/Award | 189,680 | n/a |
| Mar 1, 2023 | Coya Therapeutics, Inc. (COYA) | Grant/Award | 165,000 | n/a |
| Jan 4, 2023 | Coya Therapeutics, Inc. (COYA) | Purchase | 10,000 | n/a |